{"ticker": {"uuid": "85437d26-3e92-4f62-9467-434d0cb7acfa", "symbol": "FLNA", "name": "Filana Therapeutics, Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T07:00:00+00:00", "published_display": "16 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Filana Therapeutics (FLNA) Slides 5% as Bearish Momentum Builds; Key Support at $1.04 in Focus - ATR Stop", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQclpUajJyeWZiM1hzaVppb3dKZTZvUXJzeklNVzV4VFB3NmVVZDRRR2x0T0k4UW5qOWFyTk9BVW9IWXlIN081cGpOZ0pkdl9VM1o3NzlyNGhBOHpILVl2TTNsTVA4ZG0ycFk5YlQ0QmJvc05pSmROVHVJaGJORW85cExYMXlkcXZFSG1CMXYtRE9UaVhBMUZhOWx0dUk0b01xTGpsRUxEUXF4UjRiQzI1THoxWVVBN3BCeG1IZEJZMUh4MVdjMWpwd1R0bnk?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-14T23:43:25+00:00", "published_display": "14 Jul 2026 23:43", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Filana Therapeutics (FLNA) Holds Near Support Amid Modest Decline - ALMA Signal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUVNxWnBtUWk1Uy04RVIwb01wTWRIU2hJdE16LWprcVROV1p1WXhrZnZreXJaVVp2NEhLck5BcGU2Qk1GbjBsUFBWRW1jaWdlbnZ0N0tyYU53N1BJRFl1Q1lwRVo1TGZBUHlDOHFUejdFSWFMVVRUY2M0Sk9QZzBNNHZLelQwTEwyaW91R2lIQ1Q3cEtLTjJ1SHBDS0l4NXhFVWk3N3BUNzU?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana Therapeutics (FLNA) Slips 4.6% as Biotech Sector Headwinds Test Support - Volatility Smile", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNRWJGVGt2b0l2cDVhTEpsZ2tXRnlaNVhQc0E2MzMxVHY1eGFtRVBUYzc1R3JBblRGOHBIVkp1MWV6UG02d1R6U0wzRHpBQWtvM21lQ1JsMTl3TXdBU1ViTHZBclpVYTdqZlJDVmQyWmJHbW8zSlQ0eVVVODdNRE4tVDlYaldyWmFCdWxwR1Jhdmdsck9KaFo4NjNzbm1Ma1JyVU1LelZOOGtaT0xuUXBfenBR?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Filana Therapeutics Reports Q1 2026 Financial Results and Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPX0dZSkowMDY1VUNvWVJDU2dWUlZwQXRmV1h1WVpoT3dLWDZ2SkprQ25rMDFZOS0wUW9DazNNSEZUZDZpc29PTzRlSDYxZTc5RFhkM3d6RHpWVGxXVHNKcGpUM1FQZ1RfeFRrWkZMMkp6YkJXOW93U1BWMUlTXzBzNW1KaHd1YjZoVVgycGVtM2VGQ3lreVpCNHA4Nk0tbW5YRVItNFVYbw?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/filana-therapeutics-presents-tsc-related-120000180.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T12:00:00+00:00", "published_display": "05 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "At a Madrid epilepsy meeting, Filana detailed why it\u2019s testing simufilam", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQZXVVX1M2Wm4yLXdjYnVkZVh6ZDhFUmRXN1hRckhDOVJwM2M4Vl8xZVJIaHk0dk9DS2VqNElCZFI1Wlg2TEFROGU5QmFUd1dyczRzTXN4eTY1MlpNcjZuYWl6X0VkNDdwd3ByeXJyQlVGVHhTd0tvZVp2ZmdPUUJ4NUk5Nzh0MUYtZGV3LTJoeWxHcUdvOTVxT1AtTmwtcGxzTVd1TWRsbXhCZ0VodGgwcHUtOXlRNmRpWk5laGtn?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Technical Analysis of Filana Therapeutics, Inc. (NASDAQ:FLNA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE1VT3Vha1ZYYzVyaFJEM01JVDBRaXpScGRDU2NybUZEckpaa1pCalVHZFp2U20wOTBmNUFKdThpX1JYSXZzZmhpZ2RnVjVNMGxlMEZaZWJRZkJ2c21maXJPSFpBOW9PR1ptWjBB?oc=5", "source_name": "TradingView", "published_at": "2026-03-13T15:06:19+00:00", "published_display": "13 Mar 2026 15:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana Therapeutics, Inc. News \u2014 NASDAQ:FLNA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE93dDdSUlFmNzFsa0c3SlhDV19mWUhnMWhadmdCYWpyNlVKSVFlWnJLMkZIRXJ6YVNwVmJROC1LekVqQ0pSZlQ3MUZTcTVtOWxvb0hTV0ZLQ3g1MXZaYUZtUDhBSQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-13T15:06:19+00:00", "published_display": "13 Mar 2026 15:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart | MEXC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiR0FVX3lxTE9MWDBKNmtwdzZJLUZFZ3J5SnJSR3BtclBrazBIUjFJaS0yb05OV29Xc2FGcndySDZMYmU4MkhURTVhY3luUWpj?oc=5", "source_name": "mexc.com", "published_at": "2026-03-13T10:52:19+00:00", "published_display": "13 Mar 2026 10:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FLNA Stock Price and Chart \u2014 NASDAQ:FLNA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBCQjZQQmRhd0RsdDFxLXVabGQxZlZGVVozUlVNNFlXdTMzMWNRTk5BeTlWbFJndENEMk9pUW02bjhNUEJ6UnpVR2U3MW01S1FUaWNBLXJSLS13d3pZ?oc=5", "source_name": "TradingView", "published_at": "2026-03-11T18:48:24+00:00", "published_display": "11 Mar 2026 18:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQekJ4X19qdHJsdHJuVjFDcmttTHlCNmFOZnlOVmVCYjhzSl9lbjNUQjNyVnVmeDFPTFQ4WnlBSkQyWU93dkNsdTFxcWt0elMxV3lKaDMtN0pldmhnVlhnQmlvejRnMWR4ZmduaUF1WjdnUlg1ZVJGWkw3YldTTFljVnBWc19MVGZjNXRVMw?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana leaves Cassava roots behind amid branch into epilepsy", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPMzVQNlFuTEZLdmE5eGdzTVUzRkVVVUpRUEFJZU1FelNSS3FjS1JscnM1dXBjLVY0Nl9EQTNpelZHdTlvY1pYSm01Q09vYUNsa0MtRlNnamt5S0dUdTFSSDJ3cDBuS2o1QUVhU0M2WS1RY2V2ZUV5MmhPN0lzV2RJYm56M3Q5ckVpMzZacnpQUGx3Y2RTRnRKdDY0MDI?oc=5", "source_name": "Fierce Pharma", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Filana Therapeutics (FLNA) Slides 5% as Bearish Momentum Builds; Key Support at $1.04 in Focus - ATR Stop", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQclpUajJyeWZiM1hzaVppb3dKZTZvUXJzeklNVzV4VFB3NmVVZDRRR2x0T0k4UW5qOWFyTk9BVW9IWXlIN081cGpOZ0pkdl9VM1o3NzlyNGhBOHpILVl2TTNsTVA4ZG0ycFk5YlQ0QmJvc05pSmROVHVJaGJORW85cExYMXlkcXZFSG1CMXYtRE9UaVhBMUZhOWx0dUk0b01xTGpsRUxEUXF4UjRiQzI1THoxWVVBN3BCeG1IZEJZMUh4MVdjMWpwd1R0bnk?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-14T23:43:25+00:00", "published_display": "14 Jul 2026 23:43", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana Therapeutics (FLNA) Holds Near Support Amid Modest Decline - ALMA Signal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUVNxWnBtUWk1Uy04RVIwb01wTWRIU2hJdE16LWprcVROV1p1WXhrZnZreXJaVVp2NEhLck5BcGU2Qk1GbjBsUFBWRW1jaWdlbnZ0N0tyYU53N1BJRFl1Q1lwRVo1TGZBUHlDOHFUejdFSWFMVVRUY2M0Sk9QZzBNNHZLelQwTEwyaW91R2lIQ1Q3cEtLTjJ1SHBDS0l4NXhFVWk3N3BUNzU?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana Therapeutics (FLNA) Slips 4.6% as Biotech Sector Headwinds Test Support - Volatility Smile", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNRWJGVGt2b0l2cDVhTEpsZ2tXRnlaNVhQc0E2MzMxVHY1eGFtRVBUYzc1R3JBblRGOHBIVkp1MWV6UG02d1R6U0wzRHpBQWtvM21lQ1JsMTl3TXdBU1ViTHZBclpVYTdqZlJDVmQyWmJHbW8zSlQ0eVVVODdNRE4tVDlYaldyWmFCdWxwR1Jhdmdsck9KaFo4NjNzbm1Ma1JyVU1LelZOOGtaT0xuUXBfenBR?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana Therapeutics Reports Q1 2026 Financial Results and Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPX0dZSkowMDY1VUNvWVJDU2dWUlZwQXRmV1h1WVpoT3dLWDZ2SkprQ25rMDFZOS0wUW9DazNNSEZUZDZpc29PTzRlSDYxZTc5RFhkM3d6RHpWVGxXVHNKcGpUM1FQZ1RfeFRrWkZMMkp6YkJXOW93U1BWMUlTXzBzNW1KaHd1YjZoVVgycGVtM2VGQ3lreVpCNHA4Nk0tbW5YRVItNFVYbw?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/filana-therapeutics-presents-tsc-related-120000180.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T12:00:00+00:00", "published_display": "05 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "At a Madrid epilepsy meeting, Filana detailed why it\u2019s testing simufilam", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQZXVVX1M2Wm4yLXdjYnVkZVh6ZDhFUmRXN1hRckhDOVJwM2M4Vl8xZVJIaHk0dk9DS2VqNElCZFI1Wlg2TEFROGU5QmFUd1dyczRzTXN4eTY1MlpNcjZuYWl6X0VkNDdwd3ByeXJyQlVGVHhTd0tvZVp2ZmdPUUJ4NUk5Nzh0MUYtZGV3LTJoeWxHcUdvOTVxT1AtTmwtcGxzTVd1TWRsbXhCZ0VodGgwcHUtOXlRNmRpWk5laGtn?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Filana Therapeutics, Inc. (NASDAQ:FLNA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE1VT3Vha1ZYYzVyaFJEM01JVDBRaXpScGRDU2NybUZEckpaa1pCalVHZFp2U20wOTBmNUFKdThpX1JYSXZzZmhpZ2RnVjVNMGxlMEZaZWJRZkJ2c21maXJPSFpBOW9PR1ptWjBB?oc=5", "source_name": "TradingView", "published_at": "2026-03-13T15:06:19+00:00", "published_display": "13 Mar 2026 15:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana Therapeutics, Inc. News \u2014 NASDAQ:FLNA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE93dDdSUlFmNzFsa0c3SlhDV19mWUhnMWhadmdCYWpyNlVKSVFlWnJLMkZIRXJ6YVNwVmJROC1LekVqQ0pSZlQ3MUZTcTVtOWxvb0hTV0ZLQ3g1MXZaYUZtUDhBSQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-13T15:06:19+00:00", "published_display": "13 Mar 2026 15:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart | MEXC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiR0FVX3lxTE9MWDBKNmtwdzZJLUZFZ3J5SnJSR3BtclBrazBIUjFJaS0yb05OV29Xc2FGcndySDZMYmU4MkhURTVhY3luUWpj?oc=5", "source_name": "mexc.com", "published_at": "2026-03-13T10:52:19+00:00", "published_display": "13 Mar 2026 10:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FLNA Stock Price and Chart \u2014 NASDAQ:FLNA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTFBCQjZQQmRhd0RsdDFxLXVabGQxZlZGVVozUlVNNFlXdTMzMWNRTk5BeTlWbFJndENEMk9pUW02bjhNUEJ6UnpVR2U3MW01S1FUaWNBLXJSLS13d3pZ?oc=5", "source_name": "TradingView", "published_at": "2026-03-11T18:48:24+00:00", "published_display": "11 Mar 2026 18:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxQekJ4X19qdHJsdHJuVjFDcmttTHlCNmFOZnlOVmVCYjhzSl9lbjNUQjNyVnVmeDFPTFQ4WnlBSkQyWU93dkNsdTFxcWt0elMxV3lKaDMtN0pldmhnVlhnQmlvejRnMWR4ZmduaUF1WjdnUlg1ZVJGWkw3YldTTFljVnBWc19MVGZjNXRVMw?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Filana leaves Cassava roots behind amid branch into epilepsy", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPMzVQNlFuTEZLdmE5eGdzTVUzRkVVVUpRUEFJZU1FelNSS3FjS1JscnM1dXBjLVY0Nl9EQTNpelZHdTlvY1pYSm01Q09vYUNsa0MtRlNnamt5S0dUdTFSSDJ3cDBuS2o1QUVhU0M2WS1RY2V2ZUV5MmhPN0lzV2RJYm56M3Q5ckVpMzZacnpQUGx3Y2RTRnRKdDY0MDI?oc=5", "source_name": "Fierce Pharma", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T07:00:00+00:00", "published_display": "16 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 65, "total_relevant": 21, "sentiment_summary": {"positive": 1, "negative": 3, "neutral": 17, "score": 48, "total": 21, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 6.05, "count": 11}, {"event": "earnings", "label": "Earnings", "weight": 4.26, "count": 10}], "positive_events": 1, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 1.06, "latest_week": "2026-07-17", "one_week_move": -10.2, "four_week_move": -13.1, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -23.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 13.2479, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-10.2% over one week, -13.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 8}, {"label": "TradingView", "count": 4}, {"label": "dars.gov.et", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "GlobeNewswire", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "mexc.com", "count": 1}, {"label": "Fierce Pharma", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 12}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Earnings", "count": 10}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "12", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-10.2% over one week, -13.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Filana Therapeutics (FLNA) Slides 5% as Bearish Momentum Builds; Key Support at $1.04 in Focus - ATR Stop"}], "updated_at": "2026-07-24T15:39:39.318170+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}